Evon Winborne

743 total citations
11 papers, 482 citations indexed

About

Evon Winborne is a scholar working on Materials Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Evon Winborne has authored 11 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Materials Chemistry, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Evon Winborne's work include Enzyme Structure and Function (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (3 papers). Evon Winborne is often cited by papers focused on Enzyme Structure and Function (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (3 papers). Evon Winborne collaborates with scholars based in United States and France. Evon Winborne's co-authors include Gary L. Gilliland, T.L. Poulos, Andrew Howard, B.C. Finzel, Marc Whitlow, Alexander Wlodawer, Joseph Nachman, Krishna H. M. Murthy, Christine Debouck and Michael D. Minnich and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Evon Winborne

11 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evon Winborne United States 9 268 140 93 91 90 11 482
V. Mikol France 10 507 1.9× 182 1.3× 43 0.5× 51 0.6× 187 2.1× 19 736
Gabriela Mustata United States 14 351 1.3× 60 0.4× 10 0.1× 102 1.1× 101 1.1× 17 592
David D. Anderson United States 16 266 1.0× 16 0.1× 28 0.3× 320 3.5× 183 2.0× 26 771
Daniel J. Krosky United States 13 481 1.8× 42 0.3× 23 0.2× 66 0.7× 39 0.4× 20 574
Rebecca Rone United States 6 363 1.4× 85 0.6× 11 0.1× 126 1.4× 34 0.4× 7 627
Sara H. Thrall United States 15 413 1.5× 72 0.5× 15 0.2× 60 0.7× 225 2.5× 23 640
Kendra E. Hightower United States 13 472 1.8× 73 0.5× 14 0.2× 132 1.5× 240 2.7× 20 745
Mark E. Zupec United States 15 326 1.2× 73 0.5× 19 0.2× 115 1.3× 61 0.7× 18 546
Nils Ostermann Switzerland 12 351 1.3× 94 0.7× 14 0.2× 69 0.8× 119 1.3× 24 514
Christophe Mathé France 16 578 2.2× 35 0.3× 54 0.6× 424 4.7× 507 5.6× 71 1.1k

Countries citing papers authored by Evon Winborne

Since Specialization
Citations

This map shows the geographic impact of Evon Winborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evon Winborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evon Winborne more than expected).

Fields of papers citing papers by Evon Winborne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evon Winborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evon Winborne. The network helps show where Evon Winborne may publish in the future.

Co-authorship network of co-authors of Evon Winborne

This figure shows the co-authorship network connecting the top 25 collaborators of Evon Winborne. A scholar is included among the top collaborators of Evon Winborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evon Winborne. Evon Winborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gallagher, D. Travis, Edward Eisenstein, Kathryn E. Fisher, et al.. (1998). Polymorphous crystallization and diffraction of threonine deaminase from Escherichia coli. Acta Crystallographica Section D Biological Crystallography. 54(3). 467–469. 7 indexed citations
2.
Ilyin, Valentin, et al.. (1996). 2.9 Å crystal structure of ligand-free tryptophanyl-tRNA synthetase. Acta Crystallographica Section A Foundations of Crystallography. 52(a1). C164–C164. 2 indexed citations
3.
Hoog, Susan S., Baoguang Zhao, Evon Winborne, et al.. (1995). A Check on Rational Drug Design: Crystal Structure of a Complex of Human Immunodeficiency Virus Type 1 Protease with a Novel .gamma.-Turn Mimetic Inhibitor. Journal of Medicinal Chemistry. 38(17). 3246–3252. 30 indexed citations
4.
Thompson, Scott K., Krishna H. M. Murthy, Baoguang Zhao, et al.. (1994). Rational Design, Synthesis, and Crystallographic Analysis of a Hydroxyethylene-Based HIV-1 Protease Inhibitor Containing a Heterocyclic P1'-P2' Amide Bond Isostere. Journal of Medicinal Chemistry. 37(19). 3100–3107. 33 indexed citations
5.
Abdel‐Meguid, Sherin S., Baoguang Zhao, Krishna H. M. Murthy, et al.. (1993). Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis. Biochemistry. 32(31). 7972–7980. 66 indexed citations
6.
Zhao, Baoguang, Evon Winborne, Michael D. Minnich, et al.. (1993). Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors. Biochemistry. 32(48). 13054–13060. 15 indexed citations
7.
Murthy, Krishna H. M., Evon Winborne, Michael D. Minnich, J S Culp, & Christine Debouck. (1992). The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations. Journal of Biological Chemistry. 267(32). 22770–22778. 41 indexed citations
8.
Whitlow, Marc, Andrew Howard, B.C. Finzel, et al.. (1991). A metal‐mediated hydride shift mechanism for xylose isomerase based on the 1.6 Å Streptomycs rubiginosus structure with xylitol and D‐xylose. Proteins Structure Function and Bioinformatics. 9(3). 153–173. 168 indexed citations
9.
Gilliland, Gary L., Evon Winborne, Joseph Nachman, & Alexander Wlodawer. (1990). The three‐dimensional structure of recombinant bovine chymosin at 2.3 Å resolution. Proteins Structure Function and Bioinformatics. 8(1). 82–101. 97 indexed citations
10.
Gilliland, Gary L., Andrew Howard, Evon Winborne, et al.. (1987). Crystallization and preliminary x-ray diffraction studies of subtilisin GX from Bacillus sp. GX6644.. Journal of Biological Chemistry. 262(9). 4280–4283. 9 indexed citations
11.
Gilliland, Gary L., Evon Winborne, Yoshihiro Masui, & Yoshikatsu Hirai. (1987). A preliminary crystallographic study of recombinant human interleukin 1 beta.. Journal of Biological Chemistry. 262(25). 12323–12324. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026